ANGPTL8 Levels Associated with Hyperlipidemia in Primary Nephrotic Syndrome
|
By LabMedica International staff writers Posted on 28 Apr 2021 |

Image: The FUS-2000 automated urine analyzer (Photo courtesy of DIRUI)
The typical clinical manifestations of Primary Nephrotic Syndrome (PNS) include massive proteinuria, hypoproteinemia, edema and/or hyperlipidemia. Of these, marked proteinuria is the core clinical manifestation, and its severity often parallels the degree of hyperlipidemia.
Members of the angiopoietin-like protein (ANGPTL) family are mainly involved in vascular endothelial genesis and the regulation of lipid metabolism. Recent studies have detected ANGPTL8 in human and mouse serum, and moderate levels have been found in human urine. Studies have confirmed that ANGPTL8, ANGPTL4, and ANGPTL3 synergistically interact to participate in fatty acid transfer.
Nephrologists at the Guangzhou Women and Children's Medical Center (Guangzhou City, China) and their associates recruited 193 subjects including 133 patients with PNS and 60 healthy controls (HCs). The levels of serum cholesterol (CHOL), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), LDL-C, albumin (ALB), creatinine (CREA), urea (Ur) were measured by ARCHITECT c1600 automated biochemical analyzer (Abbott, Abbott Park, IL, USA). 24-hour urine total protein (24 hUTP), urine creatinine (UCr) were measured by the UniCel DxI 800 automated chemiluminescence immunoanalyzer (Beckman Coulter, Brea, CA, USA), and urine protein was measured by FUS-2000 automated urine analyzer (DIRUI, Changchun, China). The serum and urine ANGPTL8 concentrations were measured with ELISA kits.
The team reported that compared with healthy controls, subjects with primary nephrotic syndrome had higher levels of serum and urine ANGPTL8. In primary nephrotic syndrome patients, serum ANGPTL8 was positively correlated with cholesterol and triglycerides, while there was no correlation with 24 hour UTP. Urine ANGPTL8 was positively correlated with high-density lipoprotein cholesterol (and was significantly negatively correlated with creatinine, eGFR and 24 hour UTP. The urine ANGPTL8 concentrations in membranous nephropathy and mesangial proliferative glomerulonephritis pathological types were different.
The authors concluded that serum and urine ANGPTL8 levels in primary nephrotic syndrome patients were correlated with blood lipid levels and proteinuria, respectively, suggesting that ANGPTL8 may play a role in the development of primary nephrotic syndrome hyperlipidemia and proteinuria. The study was published on April 14, 2021 in the journal BMC Nephrology.
Related Links:
Guangzhou Women and Children's Medical Center
Abbott
Beckman Coulter
DIRUI
Members of the angiopoietin-like protein (ANGPTL) family are mainly involved in vascular endothelial genesis and the regulation of lipid metabolism. Recent studies have detected ANGPTL8 in human and mouse serum, and moderate levels have been found in human urine. Studies have confirmed that ANGPTL8, ANGPTL4, and ANGPTL3 synergistically interact to participate in fatty acid transfer.
Nephrologists at the Guangzhou Women and Children's Medical Center (Guangzhou City, China) and their associates recruited 193 subjects including 133 patients with PNS and 60 healthy controls (HCs). The levels of serum cholesterol (CHOL), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), LDL-C, albumin (ALB), creatinine (CREA), urea (Ur) were measured by ARCHITECT c1600 automated biochemical analyzer (Abbott, Abbott Park, IL, USA). 24-hour urine total protein (24 hUTP), urine creatinine (UCr) were measured by the UniCel DxI 800 automated chemiluminescence immunoanalyzer (Beckman Coulter, Brea, CA, USA), and urine protein was measured by FUS-2000 automated urine analyzer (DIRUI, Changchun, China). The serum and urine ANGPTL8 concentrations were measured with ELISA kits.
The team reported that compared with healthy controls, subjects with primary nephrotic syndrome had higher levels of serum and urine ANGPTL8. In primary nephrotic syndrome patients, serum ANGPTL8 was positively correlated with cholesterol and triglycerides, while there was no correlation with 24 hour UTP. Urine ANGPTL8 was positively correlated with high-density lipoprotein cholesterol (and was significantly negatively correlated with creatinine, eGFR and 24 hour UTP. The urine ANGPTL8 concentrations in membranous nephropathy and mesangial proliferative glomerulonephritis pathological types were different.
The authors concluded that serum and urine ANGPTL8 levels in primary nephrotic syndrome patients were correlated with blood lipid levels and proteinuria, respectively, suggesting that ANGPTL8 may play a role in the development of primary nephrotic syndrome hyperlipidemia and proteinuria. The study was published on April 14, 2021 in the journal BMC Nephrology.
Related Links:
Guangzhou Women and Children's Medical Center
Abbott
Beckman Coulter
DIRUI
Latest Immunology News
- Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk
- Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood
- Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia
- FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology
- Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier
- Blood-Based Immune Signal Could Reveal Lung Cancer Risk Before Tumors Develop
- Prototype Point-of-Care Test Aims to Improve Neonatal Sepsis Diagnosis
- Single-Tier Lyme Disease Test Shows High Sensitivity in Early Infection
- New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity
- Routine Newborn Blood Spots Can Measure GBS Antibody Levels
- New Autoantibody Test Targets Pre-Symptomatic Type 1 Diabetes Screening
- Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants
- HIV Monitoring Strategy Uses Drug Levels to Guide Resistance Testing
- Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent
- Blood Biomarker May Predict Colitis Risk in Checkpoint Inhibitor Therapy
- Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead
Channels
Molecular Diagnostics
view channel
Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis
Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more
Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection
Breast cancer screening relies primarily on mammography, but abnormal findings can lead to additional imaging, biopsy, or repeat imaging after six months, creating anxiety and potentially delaying treatment... Read more
RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more
Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool Tests
Colorectal cancer (CRC) screening depends on patient participation and completion of follow-up colonoscopy after an abnormal noninvasive result. Access barriers can make both steps difficult, particularly... Read moreHematology
view channel
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma
Severe blood loss and inadequate tissue oxygenation are leading causes of preventable death after traumatic injury. Blood products are essential in trauma care, but cold-chain storage, short shelf life,... Read moreImmunology
view channel
Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more
Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk
A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more
Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood
Food allergy is a major childhood health concern, and distinguishing persistent risk from transient sensitization can guide clinical decisions. Specific IgE antibodies may be detectable even when a child... Read moreMicrobiology
view channel
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read more
Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
Sepsis and severe infections are difficult to treat because patients with similar clinical presentations may have very different underlying immune responses. Corticosteroids are commonly used in severe... Read morePathology
view channel
Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings
Barrett’s esophagus is a precancerous condition associated with increased risk of esophageal adenocarcinoma. Routine endoscopic biopsy findings guide surveillance and therapy, but histopathology may not... Read more
Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
Digital pathology is reshaping how laboratories manage case review, image analysis, and collaboration. As diagnostic workflows become more complex, pathology teams need platforms that can support digital... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition
Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more







